Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated to v3.4.3 (replacing the previous v3.4.2).SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Primary peritoneal carcinoma to the study conditions and a Resources link for the Genetic and Rare Diseases Information Center. Updated page revision to v3.4.2 and removed the government funding lapse notice along with the previous revision note v3.4.1.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a system notice about a lapse in government funding and updated page revision from v3.4.0 to v3.4.1, with no changes to trial content or core functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; Last Update Posted; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; Last Update Posted (Estimated); No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Study Protocol and Statistical Analysis Plan PDF and related study documents were removed from the page.SummaryDifference16%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no changes to the study details, outcomes, or listed locations.SummaryDifference0.0%

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.